Northwest Biotherapeutics, Inc. (NWBO)
0.1537
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Northwest Biotherapeutics Gross Profit Margin (Quarterly) : -5.58% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.58% |
| March 31, 2026 | -71.46% |
| December 31, 2025 | -19.20% |
| September 30, 2025 | -160.5% |
| June 30, 2025 | -294.7% |
| March 31, 2025 | -32.80% |
| December 31, 2024 | -116.9% |
| September 30, 2024 | -46.22% |
| June 30, 2024 | -1.18% |
| March 31, 2024 | -77.82% |
| December 31, 2023 | 5.39% |
| September 30, 2023 | -20.44% |
| June 30, 2023 | -109.5% |
| March 31, 2023 | 54.32% |
| December 31, 2022 | 27.97% |
| September 30, 2022 | -81.07% |
| June 30, 2022 | -22.64% |
| March 31, 2022 | 60.30% |
| December 31, 2021 | |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Savara, Inc. | -- |
| Vericel Corp. | 72.82% |
| Biogen, Inc. | 61.37% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.39% |
| Return on Invested Capital | -417.1% |
| Profit Margin (Quarterly) | -1.14K% |
| Operating Margin (Quarterly) | -1.44K% |
| Return on Net Operating Assets | -70.39% |